MLchartDataset catalogue

indium In 111 bevacizumab

Term · Oncology and biomedicine · MLC-T-ONC-014411

A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody bevacizumab conjugated with the gamma-emitting radioisotope indium In 111. Indium I 111 bevacizumab binds to vascular endothelial growth factor (VEGF), allowing the detection of VEGF distribution using gamma scintigraphy.

Table 1. Record
IdentifierMLC-T-ONC-014411
FieldOncology and biomedicine
Synonyms111-indium labeled bevacizumab
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014411",
  "term": "indium In 111 bevacizumab",
  "field": "Oncology and biomedicine",
  "definition": "A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody bevacizumab conjugated with the gamma-emitting radioisotope indium In 111. Indium I 111 bevacizumab binds to vascular endothelial growth factor (VEGF), allowing the detection of VEGF distribution using gamma scintigraphy.",
  "synonyms": [
    "111-indium labeled bevacizumab"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/indium-in-111-bevacizumab/"
}

Record 9,181 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.